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The alkylation response protein AidB is localized
at the new poles and constriction sites
in Brucella abortus
Delphine Dotreppe, Caroline Mullier, Jean-Jacques Letesson and Xavier De Bolle*
Abstract
Background: Brucella abortus is the etiological agent of a worldwide zoonosis called brucellosis. This alpha-
proteobacterium is dividing asymmetrically, and PdhS, an essential histidine kinase, was reported to be an old pole
marker.
Results: We were interested to identify functions that could be recruited to bacterial poles. The Brucella ORFeome,
a collection of cloned predicted coding sequences, was placed in fusion with yellow fluorescent protein (YFP)
coding sequence and screened for polar localizations in B. abortus. We report that AidB-YFP was systematically
localized to the new poles and at constrictions sites in B. abortus, either in culture or inside infected HeLa cells or
RAW264.7 macrophages. AidB is an acyl-CoA dehydrogenase (ACAD) homolog, similar to E. coli AidB, an enzyme
putatively involved in destroying alkylating agents. Accordingly, a B. abortus aidB mutant is more sensitive than the
wild-type strain to the lethality induced by methanesulphonic acid ethyl ester (EMS). The exposure to EMS led to a
very low frequency of constriction events, suggesting that cell cycle is blocked during alkylation damage. The
localization of AidB-YFP at the new poles and at constriction sites seems to be specific for this ACAD homolog
since two other ACAD homologs fused to YFP did not show specific localization. The overexpression of aidB, but
not the two other ACAD coding sequences, leads to multiple morphological defects.
Conclusions: Data reported here suggest that AidB is a marker of new poles and constriction sites, that could be
considered as sites of preparation of new poles in the sibling cells originating from cell division. The possible role
of AidB in the generation or the function of new poles needs further investigation.
Background
Brucella is the etiologic agent of brucellosis, a world-
wide zoonosis that affects a broad range of mammals,
including humans [1]. Brucella is considered as a facul-
tative intracellular pathogen that enters various cell
types during the infection process, including macro-
phages and epithelial cells, and ultimately survives and
multiplies inside these cells [2]. After internalization,
intracellular Brucella resides within a vacuole (BCV for
Brucella-containing vacuole) that interacts with early
endosomes [3] and then transiently acquire markers of
late endosomes such as LAMP1. In epithelial cells and
macrophages, non-opsonized bacteria replicate finally in
a compartment characterized by the presence of endo-
plasmic reticulum (ER) markers [4-7].
The mechanisms used by Brucella to sense and
respond to changes within the intracellular environment
are poorly understood. Brucella spp. seem well adapted
to cope with nutritional [8] and various physicochemical
stresses encountered in non-professional and especially
professional phagocytes [9]. For example, Brucella spp.
are adapted to oxidative and nitrosative stresses [9] that
have been shown to affect genome integrity in other
bacterial species. In 2002, Köhler et al. identified an
attenuated mutant with a mini-transposon in the aidB
gene, proposed to encode an acyl-CoA dehydrogenase
homolog [10]. In Escherichia coli, AidB protein takes
part of the adaptative response to alkylating agents that
could damage the genome [11], suggesting that AidB
homolog could play a similar role in B. abortus.
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Moreover, a Brucella melitensis mutant in the alkA gene
was found to be attenuated in mice (Pascal Lestrate, Ph.
D. thesis, 2003). The alkA gene is homologous to E. coli
alkA, another gene involved in the adaptative response
to alkylating stress [12,13]. In summary, these data sug-
gests that DNA alkylation repair systems could play a
role in intracellular persistence, possibly by preventing
DNA damage that might be induced by alkylating
agents, either produced from endogenous sources [14]
or induced by the host during the infection process.
Here we report that while screening Brucella
ORFeome for polar proteins in Brucella abortus, AidB
was found to localize at the new pole, as well as at the
constriction site in dividing cells. This pattern of locali-
zation is maintained in B. abortus infecting epithelial
cells and macrophages at different times post-infection.
Analysis of an aidB mutant revealed on one hand no
effect on virulence, and on the other hand that the aidB
mutant was more sensitive to the alkylating agent
methanesulfonic acid ethyl ester (EMS), suggesting a
function of AidB in the defence against DNA methyla-
tion damage. While EMS was found to block cell cycle
before cell constriction, a B. abortus strain overexpres-
sing aidB was found to generate multipolar morpholo-
gies, suggesting a link between the response to
alkylating agents and cell growth and/or division.
Results
Screen for polarly localized proteins in Brucella abortus
To identify polar proteins at the genomic scale, we took
advantage of the Brucella melitensis ORFeome [15], a
collection of all predicted coding sequences (pCDSs)
from B. melitensis genome cloned in a donor vector
(pDONR201) allowing the Gateway recombinational
cloning. The resulting ~3200 entry clones are physically
organized in 96-well plates (34 plates), each well con-
taining one entry clone (one cloned B. melitensis pCDS).
For some large-scale experiments, the Brucella
ORFeome is also organized in 68 pools [16], each pool
being a mix of clones from one half-plate of the original
ORFeome. Each of the 68 pools was used to transfer the
pCDSs in a destination vector allowing pCDS-yfp
fusions under the control of E. coli lac promoter, on a
low copy number plasmid. More than 1000 transfor-
mants (> 10 times the diversity of the pool) were gener-
ated for each cloned pool of pCDSs. The pools of
constructions were transformed into E. coli strain S17-1
(> 1000 transformants/pool) and were transferred in a
Brucella abortus XDB1155 strain [16] by mating. The
XDB1155 strain produces the PdhS-CFP (cyan fluores-
cent protein) fusion protein from the chromosomal
pdhS locus. This strain allows the quick determination
of the nature of the pole marked by the protein-YFP
fusion since PdhS-CFP is known to specifically label the
old pole [17]. The diversity of the pCDSs in the pools
was checked by PCR and restriction analysis on isolated
clones from 5 different pools with various average
pCDSs sizes, in E. coli S17-1 and B. abortus XDB1155
strains. The analysis of restriction profiles suggests that
there is no main over-representation of a given clone in
the examined pools.
For the screening strategy, we observed the 68 pools
using fluorescence microscopy, and we selected pools in
which a fraction of the clones exhibit a polar YFP
fusion. The pooled clones were examined after cultiva-
tion on solid medium and > 1000 bacteria were
observed on agarose pads. Afterwards, pools bearing
polar localization were observed clone by clone in the
same way to identify clones producing polar proteins.
The pCDS allowing polar localization were amplified by
PCR and sequenced to allow their identification.
Before analysing the 68 pools, we first screened a pool
supposed to contain the pdhS coding sequence (CDS),
as a positive control. The complete procedure was
applied and six clones were identified as polarly loca-
lized, and all of them contained the pdhS CDS fused to
YFP. This pilot study suggested that the screening pro-
cedure was working, and that PdhS was the main polar
protein in this pool. The analysis of the 67 remaining
pools led to the selection of 8 pools for which a signifi-
cant proportion of bacteria showed polar foci. The aver-
age size of the pCDSs contained in the 8 pools was
heterogeneous, varying from 450 to 2000 bp. In one of
these 8 pools, we identified a pCDS of interest
(BMEII0671 and BAB2_0642 in B. melitensis 16M and
B. abortus 2308 genomes, respectively), that we named
aidB by homology with E. coli aidB.
Brucella AidB is member of the acyl-CoA
dehydrogenase family
Deduced AidB sequence is 551 amino acids long, with a
predicted molecular mass of 60 kDa and without pre-
dicted transmembrane segments. The AidB sequence is
similar to acyl-CoA dehydrogenases (ACADs), proteins
generally involved in the fatty acid b-oxidation. In the B.
melitensis 16M genome, eight pCDSs are proposed to
encode enzymes similar to ACADs. B. melitensis and B.
abortus AidB deduced sequences are 100% identical.
Brucella AidB presents 42% identity to the Escherichia
coli AidB (E value of 4 10-117 when B. abortus AidB
deduced sequence is blasted against E. coli genomes),
suggesting a functional conservation between these
enzymes. This is further supported (1) by the conserva-
tion of the Glu-Gly catalytic pair at positions 425 and
426 (433 and 434 in Brucella AidB), (2) by the conserva-
tion of 9 of the 10 residues involved in FAD binding,
the non-conserved residue being a Ser residue replaced
by a Thr at position 198 of B. abortus AidB, and (3) the
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similarity of the regions involved in the formation of the
tetrameric structure of E. coli AidB (10 residues identi-
cal on 19 residues). Moreover, a specific feature of E.
coli AidB, compared to other members of the ACADs
family, is the presence of a Trp424 residue, involved in
the shaping of the substrate-binding pocket. This resi-
due is conserved in B. abortus AidB (Trp432). Alto-
gether, these data suggest that B. abortus AidB could
play a similar role as E. coli AidB, except that the region
of E. coli AidB involved in DNA binding (about 100 C-
terminal residues, Additional file 1 for sequence align-
ment and Additional file 2 for three-dimensional
model), is not conserved in B. abortus AidB. This sug-
gests that B. abortus AidB could be unable to bind
DNA, or would bind a very different sequence. Indeed,
in E. coli AidB is a multifunctional protein proposed to
be involved in the destruction of alkylating agents before
they reach DNA [18] and in the transcriptional control
of the aidB promoter [19]. It is thus possible that only
the enzymatic activity of AidB is conserved in B. abor-
tus, and not its ability to bind a specific DNA sequence
in the aidB promoter. In E. coli, exposition to alkylating
agents stimulates expression of aidB, ada, alkA and
alkB genes [20], Ada, AlkA and AlkB proteins being
actively involved in the repair of alkylated DNA [21].
Ada, AlkA and AlkB homologs are found in the Brucella
genomes (data not shown), suggesting that these bac-
teria are able to resist to an alkylation stress.
The aidB mutation leads to increased sensitivity to the
DNA-alkylating agent EMS
To investigate the putative function of B. abortus AidB
protein, we tested the effect of the aidB mutation on
the survival during an alkylating stress. A B. abortus 544
strain with a disrupted aidB gene was constructed
(XDB1121 strain). An aidB overexpression strain was
constructed by inserting a medium-copy plasmid
(pDD003) bearing the aidB coding sequence in B. abor-
tus, generating the XDB1122 strain. The disruption and
overexpression strains (XDB1121 and XDB1122, respec-
tively) were analyzed for their sensitivity to the alkylat-
ing agent EMS. In summary, the parental strain, the
disruption strain (XDB1121), the overexpression strain
(XDB1122) and the complemented strain (XDB1127)
were incubated in 2YT medium with 0.2, 0.4 and 1.0%
EMS for 4 h at 37°C. The alkylating agent was then
removed, and serial dilutions of the cultures were plated
on 2YT agar. The number of colony forming units (c.f.
u.) was determined and the percentage of survival after
treatment was expressed by comparison to a culture of
these different strains without EMS. A representative
result is shown in Figure 1. After exposure to EMS (0.2
to 1%), the disruption strain (XDB1121) was more sensi-
tive than the parental strain and the disruption strain
complemented with a low copy plasmid carrying the
aidB-yfp fusion (XDB1127). This data was confirmed by
reconstructing three independent B. abortus aidB
mutants that were more sensitive than the wild-type
strain to the presence of 0.4% EMS for 4 h. Indeed,
we observed 10.2% ± 2.0 survival for the aidB mutants
(n = 3), compared to 62% survival for the wild-type
strain. This phenotype was complemented for the three
strains, since we observed 61.3% ± 9.1 survival after 4 h
in 0.4% EMS for the three aidB mutants complemented
with the pDD001 plasmid (Table 1). In order to confirm
that aidB mutant was more sensitive to alkylating
agents and not just EMS, we also tested the sensitivity
of the aidB mutant and wild type strain to methyl
methanesulfonate (MMS), another alkylating agent.
After 4 h of incubation with 0.02% MMS in rich med-
ium, 45% of survival was obtained for the wild type
strain, while only 2.1% of the aidB mutants survived,
according to c.f.u. counting. Altogether, these experi-
ments indicate that the B. abortus aidB gene is probably
involved in the repair or the prevention of alkylation
damage, as suggested by its homology with E. coli AidB.
It also indicates that AidB remains active when it is
fused to YFP.
AidB-YFP is localized at the new pole, and at the
constriction site in dividing cells
The localization of the AidB-YFP fusion protein was
analyzed in a B. abortus strain carrying a chromosomal
pdhS-mCherry fusion (XDB1128 strain) during the expo-
nential growth phase in liquid cultures, in rich medium
(Figure 2A). In these conditions, the localization of the
AidB-YFP fusion protein displayed three patterns,
Figure 1 The B. abortus aidB mutant is more sensitive to EMS.
The sensitivity of B. abortus wild-type, aidB mutant strain,
complemented aidB mutant and aidB overexpression strains was
scored by counting the c.f.u. recovered after 4 h of incubation 2YT
medium at 37°C, in the presence of 0.2, 0.4 or 1% EMS. The results
are expressed as the percentage of c.f.u. compared to a control in
which EMS was omitted. Bacteria were obtained from cultures
stopped during exponential growth phase.
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depending on the presence or the absence of a constric-
tion site. In bacteria without detectable constriction,
AidB-YFP localized at the new pole and PdhS-mCherry
at the old pole in 66% of the bacteria (n = 125), with
34% of bacteria labelled only with polar AidB-YFP and
not PdhS-mCherry. In the bacteria displaying a constric-
tion site, 65% (n = 84) displayed a single AidB-YFP
focus at the constriction site, while the remaining 35%
have two foci of AidB-YFP, one at the “young” pole and
one at the constriction site. Here we define a “young”
pole as a new pole that is becoming old, because bac-
teria show a detectable constriction, meaning that there
is uncertainty about the completion of cytokinesis, and
therefore uncertainty about the status of this pole (either
new or old). We never observed the PdhS-mCherry and
AidB-YFP fusions at the same pole (n = 256) (Figure
2A). Western blots analysis using an anti-GFP antibody
on this strain suggested that AidB-YFP fusion was stable
when it was produced from the low-copy plasmid
pDD001 (data not shown). As proposed in the
model depicted in the discussion, the cells labelled with
polar AidB-YFP without polar PdhS-mCherry could
correspond to bacteria produced by division of cells car-
rying PdhS-mCherry at the old pole and AidB-YFP at
the constriction site. Indeed, after cell division, one of
the two cells does not inherit PdhS-mCherry from the
mother cell, but AidB-YFP at the constriction site is
proposed to be transmitted to the new pole of this
daughter cell.
Interestingly, the cells harbouring the two AidB-YFP
foci are significantly (p < 0.005) smaller (1.93 μm on
average) than the bacteria having a single focus of AidB-
YFP at the constriction site (2.08 μm on average), sug-
gesting that in the cell cycle, bacteria with 2 foci precede
those with a single focus at the constriction site (Figure
3A). This feature of the cell cycle is depicted in the
discussion.
Furthermore, the localization of AidB-YFP is still at
the new pole after 4 h of exposure with 0.4% EMS (80%
of the bacteria exhibited PdhS-mCherry at one pole and
AidB-YFP at the opposite pole, n = 237). This observa-
tion indicated that AidB-YFP is not released from the
new pole in the presence of an alkylating stress with
EMS, further suggesting that AidB is active at the new
pole, because in these conditions an aidB mutant is
killed. Interestingly, bacteria exposed to EMS displayed
detectable constriction at the much less frequency (2
constrictions observed among 254 bacteria) compared to
the untreated control (44 constrictions observed among
254 bacteria). Moreover, bacteria treated with 0.4% EMS
for 4 h and were significantly (p < 0.001) longer on
average than unconstricted bacteria that were not
exposed to EMS (Figure 3B). This suggests that growth
is not arrested by the presence of EMS, while constric-
tion is clearly inhibited. This is consistent with a replica-
tion arrest caused by alkylation of the bacterial genome,
as previously reported for E. coli [22].
AidB polar localization persists inside host cells
B. abortus is an intracellular pathogen that encounters
various stresses during its life cycle [9]. Since these
stresses could result in the alkylation of DNA, e.g.
through nitrosative stress [14], we tested the localization
pattern of AidB-YFP in B. abortus (XDB1120 strain)
during an infection of human epithelial cells (HeLa
cells). At 6 h and 24 h post-infection, infected cells were
fixed, and bacteria were detected using a monoclonal
anti-lipopolysaccharide antibody. The polar foci of
AidB-YFP were similar to those observed in bacteriolo-
gical culture, suggesting that in these conditions, there
is no systematic delocalization of AidB-YFP. Similar
results were also obtained with XDB1120 strain in
RAW264.7 macrophage infection. At 2 h, 4 h, 6 h and
24 h post-infection, AidB-YFP fusion proteins were still
polar (Figure 2B).
Table 1 Strains and plasmids
Strain Relevant Genotype or Description Reference or
Source
B. abortus
544 NalR Nalidixic acid-resistant B. abortus 544 J-M. Verger
XDB1155 B. abortus 544 pdhS-cfp [16]
XDB1120 XDB1155 + pDD001 This study
XDB1121 Disrupted aidB in B. abortus 544 NalR This study
XDB1122 XDB1155 + pDD003 This study
XDB1123 XDB1155 + pDD007 This study
XDB1124 XDB1155 + pDD008 This study
XDB1127 XDB1121 + pDD001 This study
XDB1118 B. abortus 544 with integrated
pCVDH07
This study
and [33]
XDB1128 XDB1118 + pDD001 This study
E. coli
DH10B Cloning strain Invitrogen
S17-1 RP4-2, Tc::Mu,Km-Tn7, for plasmid
mobilization
[26]
Plasmid Relevant Genotype or Description Reference or
Source
pDONR201 BP cloning vector Invitrogen
pRH005 Gateway-compatible YFP low copy
vector
[34]
pRH016 Gateway-compatible pBBR1-MCS1-3HA [34]
pDD001 pRH005 carrying aidB This study
pDD002 pDONR201 carrying aidB This study
pDD003 pRH016 carrying aidB This study
pDD007 pRH016 carrying acaD1 This study
pDD008 pRH016 carrying acaD2 This study
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Figure 2 The B. abortus AidB-YFP is localized at new poles and at constriction sites, in culture and in macrophages. The B. abortus
XDB1128 strain was carrying an aidB-yfp fusion on a low copy plasmid, and pdhS-mCherry at the pdhS chromosomal locus. (A) Bacteria were
grown in rich medium and the pictures were taken in exponential phase. Differential interference contrast (DIC) is shown on the left. The white
arrowheads indicate the dividing cell in which two AidB-YFP foci are detectable. Each scale bar represents 2 μm. The bacterial types are
schematically drawn on the right side of the pictures, as they are represented in figure 6. The two upper panels were made with non-diving
bacteria, and counting was made with 125 bacteria. The two lower panels were made with dividing bacteria, and counting was made on 84
dividing bacteria. (B) RAW264.7 macrophages were infected for 2, 4, 6, or 24 h with the B. abortus strain expressing aidB-yfp (XDB1120). The
infected cells were fixed and immunostained with 12G12 anti-lipopolysaccharide ("a-LPS”) primary antibody and anti-mouse secondary antibody
coupled to Texas Red. A majority of the bacteria present a single focus of AidB-YFP, suggesting that polar localization of this fusion is also
occurring during the infection of macrophages.
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Morphological analysis of aidB disruption and
overexpression mutants
Since AidB-YFP is mainly polar, we tested whether
either a disruption or an overexpression of the aidB
gene affects growth, bacterial morphology, and virulence
in cellular models of infection. The growth curve of an
aidB mutant (XDB1121) strain was similar to the wild-
type control in 2YT medium (Figure 4). The aidB
mutant strain (XDB1121) was morphologically indistin-
guishable from the wild-type strain (data not shown and
Figure 5). The localization AidB-YFP fusion protein
(expressed from pDD001) was similar in the aidB
mutant compared to the wild-type strain (data not
shown), suggesting that polar localization of AidB-YFP
does not depend on the presence of endogenous AidB,
not fused to YFP. The virulence of the aidB mutant in
HeLa cells and RAW264.7 macrophages was also similar
to the wild-type strain (data not shown and Additional
file 3). In summary, the aidB gene seems to be dispensa-
ble for growth in bacteriological medium, maintenance
of cell shape and for B. abortus virulence in a cellular
model of infection.
The growth curve of the strain expressing aidB-yfp
(XDB1120) in rich media (2YT or tryptic soy broth) is
abnormal compared to the wild-type strain (Figure 4).
Indeed, the OD during the stationary phase is lower OD
with the XDB1120 strain compared to the wild-type
control. In stationary phase in 2YT medium, the OD of
the aidB overexpression strain is even decreasing while
the OD of the wild-type control remained stable. This
correlates with a higher frequency of dead cells in the
aidB overexpression strain XDB1122 (22.8% in station-
ary phase, n = 400) compared to the wild-type strain
(5.2% dead cells, n = 400) or the wild-type strain with
an empty pBBR1 plasmid (6.7% dead cells, n = 400), the
backbone of the aidB overexpression plasmid in
XDB1122 strain. This observation suggests that aidB
overexpression is partially lethal in stationary phase. In
stationary phase cultures of the XDB1120 strain, the
bacteria display abnormal morphologies at much higher
frequency (22%; n = 200) than the wild-type strain (<
1%; n = 200). This phenotype is probably due to the
overproduction of AidB-YFP because the aidB overex-
pression strain (XDB1122) displayed similar morphologi-
cal defects (61%; n = 200) (Figure 5). Among these
abnormal morphologies, bacteria with multipolar shapes
were very frequent, swollen cells were often observed, as
well as Y-shaped bacteria, elongated cells and minicells.
The morphological phenotype of this strain is thus
pleiotropic. The analysis of AidB-YFP and PdhS-CFP
localization in XDB1120 bacteria with aberrant
morphologies, during the exponential growth phase, did
not yield a systematic localization pattern, the AidB-YFP
and PdhS-CFP fusions being often diffuse in the bacter-
ium (data not shown).
Subcellular localization and overproduction effects of
AidB are specific to this acyl-CoA dehydrogenase
homolog
Since AidB is a member of the 8 ACADs paralogs, we
wondered if the particular localization of AidB-YFP and
the presence of multipolar forms for the aidB overex-
pression mutant were specific characteristics of this
ACAD homolog. We chose two B. abortus ACAD
homologs that are stably produced at a detectable level
using Western blot (data not shown). Both paralogs
were annotated (BAB2_0433 and BAB2_0216,
Figure 3 Size distribution of B. abortus carrying AidB-YFP, in
the presence or absence of an alkylating agent (EMS). The
bacterial lengths were grouped in classes of 0.25 μm, and the
maximum value for each class is given on the × axis. (A) Size
distribution of 276 bacteria (XDB1128 strain) with AidB-YFP either at
the new pole (white), the new pole and the constriction site (dark
grey), or the constriction site only (black). (B) Size distribution of B.
abortus (XDB1128 strain) exposed to 0.4% of EMS for 4 h (light grey,
n = 340) or the unexposed control (white, n = 218, bacteria without
detectable constriction). (C) DIC and fluorescence pictures of the
XDB1128 strain expressing aidB-yfp and pdhS-mCherry fusions, as
described in figure 2. The bacteria in the lower panels have been
exposed to 0.4% EMS for 4 h in rich (2YT) medium. On the top
panels, control bacteria were incubated for 4 h in 2YT in the
absence of EMS. Constriction sites are indicated by arrowheads.
Each scale bar represents 2 μm.
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respectively named AcaD1 and AcaD2) as ACADs and
would be involved in the fatty acid b-oxidation pathway.
We observed that both ACADs homologs had a diffuse
localization in the cytoplasm when fused to YFP
(XDB1123 and XDB1124 strains, data not shown),
suggesting that the particular localization of AidB-YFP
(at young poles and at the constriction site in dividing
cells) is not a common characteristic shared by all
ACADs homologs in B. abortus. The phenotype of the
strains overproducing one of these two ACADs
Figure 4 Growth defect of the B. abortus strain expressing the aidB-yfp fusion (XDB1120). The growth of B. abortus wild-type, aidB mutant
and XDB1120 (pMR-aidB-yfp) strains was followed by recording OD at 600 nm in a Bioscreen. Duplicates (1) and (2) are shown for each strain, for
2YT (left panel) or tryptic soy broth (right panel) as culture media. In both culture media, the OD600 during stationary culture phase of the
XDB1120 strain is lower compared to the wild type control.
Figure 5 Morphological defect of the B. abortus aidB overexpressing strain. Differential interference contrast (DIC) images were taken with
bacteria of the aidB (aidB+++), acaD1 (acaD1+++) and acaD2 (acaD2+++) overexpression strains, the aidB disruption strain, and the wild-type strain
with or without the control pBBR1MCS plasmid [32], without insert. Two panels are shown for the aidB overexpression strain, the only strain
displaying a morphological defect during stationary culture phase. The morphological defects are multiple, with multipolar bacteria (M), Y-
shaped cells (y), swollen cells (s) and some minicells (m).
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homologs is similar to the B. abortus pdhS-cfp control
strain (Figure 5), with a very low frequency (< 1%) of
morphological defects. This suggests that overexpression
of any ACAD gene does not produce a morphological
defect in B. abortus, further supporting a specific
-although probably indirect- role of aidB in events
related to morphogenesis.
Discussion
The screen of the ORFeome for polar localization
allowed the identification of AidB, that shows a clear
localization pattern at new poles as well as at constric-
tion sites and/or at young pole in cells in division in
bacteriological medium. The polar localization of AidB-
YFP is preserved in HeLa cells and RAW264.7 macro-
phages at different times post-infection. We therefore
propose that AidB is a marker of new poles and con-
striction sites. To the best of our knowledge, it is the
first time that a particular subcellular localization is
described for one of the actors involved in the alkylation
damage repair. Interestingly, the constriction site corre-
sponds to the location of the future new poles just after
completion of cell division. We therefore propose a
model (Figure 6) in which AidB-YFP is not only loca-
lized at the new pole, but also at the constriction site in
dividing cells, a mechanism by which AidB-YFP would
be ideally localized for a localization at the new pole in
newly formed sibling cells. This model implies that
when new poles mature to old poles, after cell division,
they are no longer labelled with AidB-YFP (Figure 6).
In the conditions tested, overexpression of aidB leads
to bacteria with aberrant morphology (Figure 5). This
could be due to defects in cell division, cell growth or
coordination between both. One hypothesis would be
that AidB could indirectly contribute to the generation
of new poles, and overexpression of aidB would result
in the generation of additional new poles, forming bac-
teria with abnormal morphology, e.g. multipolar shapes
(Figure 5). The selective advantage of the polar localiza-
tion of AidB is unknown, but it could be related to its
role in the adaptative response to alkylating agents, sug-
gested here to block cell cycle before cell division (Fig-
ure 3B). This would be consistent with a role of AidB in
limiting alkylating damage to DNA, which would logi-
cally block replication initiation and/or progression.
The B. abortus AidB protein has a high level of iden-
tity (42%) to E. coli AidB, suggesting functional conser-
vation between the two proteins. This prediction is
supported by the increased sensitivity of the B. abortus
aidB mutant strain to the alkylating agent EMS com-
pared to the wild-type control (Figure 1). Brucella gen-
omes contain the ada, alkA and alkB genes necessary
for an adaptative response to alkylation damage similar
to the one reported for E. coli [11]. We propose that
one possible function of AidB would be to help in the
detoxification of some alkylating agents, like in E. coli.
These alkylating agents could be found at particular
stages of the infection in the natural hosts, or generated
by the bacteria themselves [14]. The absence of attenua-
tion of the aidB mutant in HeLa cells or in RAW264.7
macrophages suggests that such alkylating agents are
not crucial for the control of the number of c.f.u. during
infection of these cell lines. Our data do not confirm
the previous observation that a transpositional aidB
mutant was attenuated in THP-1 macrophages [10],
unless these specific macrophages have specific features
differentiating them from RAW264.7 macrophages for
the generation of an alkylating stress. In Salmonella
enterica, an aidB mutant was more sensitive than the
wild-type strain to several alkylating agents but pre-
sented no effect on the virulence in the mouse model.
Indeed, the virulence of a S. enterica mutant defective in
all genes specifically involved in DNA alkylation damage
repair was not affected [23].
Recently, in C. crescentus, Radhakrishnan et al.
reported that KidO, an NAD(P)-binding oxidoreductase
homolog with conserved residues in its NAD(P)-binding
pocket, acts directly on the FtsZ tubulin [24]. Localiza-
tion of KidO to the Z-ring is disrupted by mutations in
the cofactor-binding pocket that disturb the association
with NAD(P), implying that NAD(P) binding is
Figure 6 Model for the localization of AidB-YFP along B.
abortus cell cycle. The PdhS-mCherry is labelling the old pole of B.
abortus. AidB-YFP is therefore localized at the new pole, as
suggested by Figure 2. In dividing cells, we hypothesize that AidB-
YFP is first present at the young pole (the new pole that becomes
old) and at the constriction site. This localization at the young pole
would be lost afterwards, allowing the generation of two sibling
cells with a unique pole of AidB-YFP. The new (n), young (y) and
old (o) poles are labelled. In this model, the constriction region
would be the preparation site for the new poles of the sibling cells.
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important for the recruitment of KidO to the Z-ring
[24]. In this context, it should be interesting to con-
struct a mutated AidB defective for FAD binding and
observe the impact of this mutation on the AidB-YFP
localization. Finally, the selective advantage of AidB
recruitment at the new pole remains to be discovered.
One possibility would be that crucial regions of the
nucleoid located close to the new pole, such as replica-
tion origins, could be more protected from alkylating
agents. This would resemble the proposed specific pro-
tection of genes by AidB in E. coli [25] that would be
dependent on subcellular localization of AidB in B.
abortus. The aberrant morphology of the strain overex-
pressing aidB indicates that either growth or division
are affected, which suggest that AidB could be (indir-
ectly) involved in the control of these processes, for
example by providing a checkpoint for cell division.
Conclusion
AidB is induced during alkylation damage response in E.
coli, however its molecular function is mostly unknown.
Here we report that a B. abortus aidB mutant is more
sensitive to EMS, suggesting that AidB is playing a func-
tional role in the response to alkylation damage. The
AidB-YFP fusion is a marker of new poles (Figures 2
and 6). The AidB-YFP fusion is also localized to con-
striction sites, which could be considered as preparation
sites for new poles in dividing cells. AidB molecular
function at the new pole is unknown, but it is expected
to be active at this site, since its new pole localization is
preserved in B. abortus exposed to EMS. Our data also
suggest that exposure to EMS blocks the cell cycle
before the constriction event, presumably before or dur-
ing genome replication. The characteristic multipolar
morphology of the aidB overexpression strain suggests
that AidB could (indirectly) play a role in growth or cell
division of B. abortus.
Methods
Strains, plasmids and cell growth
All Brucella strains used in this study (Table 1) were
derived from B. abortus 544 NalR (a spontaneous nali-
dixic acid-resistant mutant of B. abortus 544 strain),
and were routinely cultivated in rich medium 2YT (1%
yeast extract, 1.5% tryptone and 0.5% NaCl, with 1.5%
agar for solid medium). E. coli strains DH10B (Invitro-
gen Life-Technologies) and S17-1 [26] were cultivated
in LB broth (0.5% yeast extract, 1% tryptone, 0.5%
NaCl) with streptomycin. Antibiotics were used at the
following concentrations when appropriate: nalidixic
acid, 25 μg/ml; kanamycin, 20 μg/ml; chloramphenicol,
20 μg/ml. Plasmids were mobilized from E. coli strain
S17-1 into B. abortus as previously described [27].
Growth curves were monitored using a Bioscreen
system (Thermo Fisher, ref. 110001-536), allowing con-
tinuous monitoring for growth curves in a multiwell
format. B. abortus liquid cultures in 2YT medium with
the appropriate antibiotic were centrifuged, washed
once with PBS and diluted to an OD600 of 0.1 in 2YT
(or tryptic soy broth) to start the culture in the Biosc-
reen system. Each culture (200 μl per well) was per-
formed at 37°C.
Control of the B. abortus strain used for the localization
screen
The fact that the XDB1155 strain is viable and does not
present any apparent morphological defects or growth
delay suggests that the CFP fusion at the C-terminal of
PdhS is not affecting PdhS essential functions. Control
immunoblots with anti-GFP antibodies revealed that
this fusion protein was stable (data not shown). Obser-
vation using fluorescence microscopy showed that
PdhS-CFP accumulated at one pole in more than 90%
of the cells as previously described [17].
Molecular techniques
DNA manipulations were performed according to stan-
dard techniques [28]. All plasmids used in this study
(Table 1) were constructed by the Gateway™ technique
(Invitrogen). To construct an aidB disruption mutant
strain, a central 380-bp portion of the aidB CDS was
amplified by PCR using AcoA and AcoB primers, and
was subcloned into at the EcoRV site of pSKoriTkan
vector [29]. The recombinant plasmid was transformed
into the E. coli strain S17-1 and introduced into B. abor-
tus 544 NalR strain by mating. Clones in which the plas-
mid integrated in the genome were selected by growing
the bacteria in the presence of kanamycin, and were
checked by PCR using AcoDHP1 and pGEM-T-aval pri-
mers. Since B. abortus and B. melitensis are nearly iden-
tical at the genomic level, entry clones were recovered
from the B. melitensis ORFeome version 1.1 [15]. LR
recombination cloning procedure was performed as
recommended by the manufacturer (Invitrogen Life-
Technologies). The sequences of primers are available in
Table 2.
Western blotting
For every fluorescent observations reported in this
study, we carried out Western blot analyses with antibo-
dies against YFP and CFP. These results allowed us to
rule out the possibility that a particular localization pat-
tern could result from protein degradation or from a
deficiency in fusion protein production. Western blot
analysis was carried out as described previously [8] with
monoclonal antibodies against GFP (JL8, BD Bios-
ciences) at 1/1000 dilution to check the stability of
translational fusions to YFP or CFP.
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Microscopy
For fluorescence imaging, cell populations of B. abortus
strains were immobilized on a microscope slide that was
layered with a pad of 1% agarose containing phosphate-
buffered saline (PBS) [30]. These slides were placed on a
microscope stage at room temperature. Samples were
observed on a Nikon i80 fluorescence microscope
through a differential interference contrast (DIC, Nor-
marski) 100X objective with a Hamamatsu Orca-ER
LCD camera. Images acquisition and processing were
done with NIS element (Nikon) software.
The detection of dead cells was performed with the
Live/Dead BacLight kit L7007 (Invitrogen), according to
manufacturer instructions.
Treatment of B. abortus strains with
a DNA-alkylating agent
B. abortus strains were grown in 2YT at 37°C overnight,
centrifuged and the pellet was resuspended in PBS to a
cell density of 109 c.f.u./ml (optical density of 0.33 at
600 nm). 500 μl of these cell suspensions were diluted
into 5 ml of 2YT and exposed to methanesulphonic acid
ethyl ester (EMS) at final concentrations of 0, 0.2, 0.4
and 1.0%. These suspensions were incubated at 37°C
with shaking for 1 h or 4 h, and aliquots (1 ml) were
recovered, washed once in PBS, and serially diluted in
PBS. 100 μl of these cell suspensions were spread on
individual 2YT agar plates. These plates were incubated
for 72 h at 37°C, and the c.f.u. were enumerated.
Cellular infection and immunofluorescence labelling
Infections and immunofluorescence of HeLa cells and
RAW264.7 macrophages by the different B. abortus
strains were performed as described previously [6]. Anti-
Brucella lipopolysaccharide O-chain monoclonal anti-
body 12G12 [31] was used. The secondary antibody
used was Texas red-conjugated anti-rabbit IgG (Molecu-
lar Probes) diluted 500 times.
Additional material
Additional file 1: Sequence alignment between E. coli and B.
abortus AidB. Alignment of E. coli and B. abortus AidB highlighting the
conserved parts of these enzymes, and the absence of high similarity in
the C-terminal portion of these proteins.
Additional file 2: 3D structure of E. coli AidB and 3D model of B.
abortus AidB. The 3D model of B. abortus AidB suggests that while
regions involved in tetramer formation are conserved, the C-terminal
domain involved in DNA binding is not conserved.
Additional file 3: Infection of RAW264.7 macrophages with wild-
type and aidB mutants strains. c.f.u. countings during macrophages
infection show that aidB mutation or overexpression does not
dramatically impair intracellular survival and replication of B. abortus.
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